Sanofi | SNY - Trade Creditors




Sanofi reported 7.43B in Trade Creditors for its fiscal quarter ending in June of 2024.

Trade Creditors Change Date
AbbVie 30.12B 1.09B Sep/2024
Amgen USD 19.55B 17.4B Dec/2024
AstraZeneca 22.46B 781M Dec/2024
Bristol-Myers Squibb USD 3.6B 133M Dec/2024
Canopy Growth CAD 25.49M 50.74M Jun/2024
Corcept Therapeutics USD 18.58M 900K Sep/2024
Drreddys Laboratories INR 35.78B 1.67B Sep/2024
Eli Lilly USD 2.89B 38.3M Sep/2024
Galapagos EUR 98.88M 16.98M Dec/2024
GlaxoSmithKline 15.34B 960M Dec/2024
Glaxosmithkline 13.47B 1.15B Sep/2024
Indivior 50M 4M Sep/2024
J&J USD 8.95B 106M Sep/2024
Merck USD 3.59B 1.63B Sep/2024
Novartis USD 4.57B 485M Dec/2024
Novartis USD 4.09B 59M Sep/2024
Pacira USD 19.37M 637K Sep/2024
Perrigo USD 458.5M 13M Sep/2024
Pfizer USD 5.31B 208M Sep/2024
Prestige Brands USD 19.51M 11.67M Dec/2024
Roche Holding 4.35B 828M Dec/2024
Sanofi 7.43B 105M Jun/2024
Sanofi 7.43B 105M Jun/2024
Supernus Pharmaceuticals USD 6.39M 1.76M Sep/2024
UCB 2.42B 1.88B Jun/2024
Zoetis USD 433M 29M Dec/2024